AL

Ares Life Sciences

Europe, Geneve, Switzerland, Geneva

Description

Ares Life Sciences is a venture capital firm specializing in expansion and late stage investments.

Investor Profile

Ares Life Sciences has backed more than 2 startups, with 0 new investments in the last 12 months alone. The firm has led 2 rounds, about 100% of its total and boasts 2 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series G, Post Ipo Equity rounds (top funding stages).
  • Majority of deals are located in United States, Switzerland.
  • Strong thematic focus on Biotechnology, Health Care, Medical.

Stage Focus

  • Series G (50%)
  • Post Ipo Equity (50%)

Country Focus

  • United States (50%)
  • Switzerland (50%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Medical Device
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Ares Life Sciences frequently co-invest with?

Abingworth
Europe, England, United Kingdom, London
Co-Investments: 1
JAIC America
North America, California, United States, Palo Alto
Co-Investments: 1
HBM Healthcare Investments
Europe, Zug, Switzerland, Zug
Co-Investments: 1
Pac-Link
Asia, T'ai-pei, Taiwan, Taipei
Co-Investments: 1
Charter Venture Group
North America, Texas, United States, Houston
Co-Investments: 1
Menlo Ventures
North America, California, United States, San Francisco
Co-Investments: 1
Saints Capital
North America, California, United States, San Francisco
Co-Investments: 1
SightLine Partners
North America, Minnesota, United States, Minneapolis
Co-Investments: 1

What are some of recent deals done by Ares Life Sciences?

Broncus Technologies

Mountain View, California, United States

Broncus Technologies is a medical technology company developing minimally-invasive medical devices for emphysema and other lung diseases.

BiotechnologyHealth CareMedicalMedical Device
Series GDec 5, 2008
Amount Raised: $38,000,000
Santhera Pharmaceuticals

Liestal, Basel-Landschaft, Switzerland

Santhera Pharmaceuticals develops and markets pharmaceutical products for the treatment of mitochondrial and neuromuscular diseases.

BiotechnologyHealth CarePharmaceutical
Post Ipo EquityNov 6, 2008
Amount Raised: $13,533,262

Find More Investors Like Ares Life Sciences

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

Ares Life Sciences | Pipeseed